Clonidine prolongs spinal anesthesia in newborns: a prospective dose-ranging study

Area of Science:

• Anesthesiology
• Pediatric Surgery

Background:

• Spinal anesthesia in neonates reduces morbidity compared to general anesthesia.
• Bupivacaine alone may provide insufficient surgical anesthesia duration in up to 40% of neonates.
• Clonidine is known to prolong spinal anesthesia in adults and caudal blocks in children.

Purpose of the Study:

• To evaluate the dose-dependent effect of clonidine on the duration of spinal anesthesia in neonates.
• To determine the optimal dose of clonidine for extending spinal block duration without significant side effects.

Main Methods:

• A controlled, prospective, dose-ranging study involving 75 neonates undergoing elective inguinal herniorrhaphy.
• Patients received spinal anesthesia with bupivacaine plus varying doses of clonidine (0, 0.25, 0.5, 1, or 2 micro g/kg).
• Hemodynamic (mean arterial blood pressure, heart rate), respiratory (SpO2), and block characteristics were monitored.

Main Results:

• The duration of spinal block significantly increased with clonidine, reaching 111 minutes with 1 micro g/kg compared to 67 minutes in the control group (P < 0.003).
• Hemodynamic and respiratory parameters remained similar across all groups.
• Transient hypotension and increased caffeine administration were noted at the highest clonidine dose (2 micro g/kg).

Conclusions:

• Clonidine at 1 micro g/kg significantly prolongs spinal anesthesia duration in neonates, effectively doubling the block time.
• This dose offers a safe and effective method to improve spinal anesthesia suitability for neonatal surgery.
• Higher doses of clonidine may increase the risk of transient hypotension.